Oral GLP-1 Therapy
No needles. No drama.
Just the science, in a tablet.
You don't need to lose 100 pounds to benefit from GLP-1 therapy. Oral semaglutide offers the same mechanism in a daily tablet — approachable, flexible dosing, and backed by the same clinical evidence.
This isn't just for dramatic weight loss.
The health optimizer
You're not “overweight” by much — maybe 15-30 lbs. But you understand that systemic inflammation, cardiovascular risk, and metabolic health matter long before you hit a clinical threshold. You want to act early, not react late.
The informed pragmatist
You've read the data. You know GLP-1 agonists reduce CRP by 35-40%, cut cardiovascular events by 20%, and protect organs you're not even thinking about yet. You want in — at a dose that makes sense for prevention, not just treatment.
The needle-averse
Weekly injections aren't for everyone. The oral form gives you the same compound — same mechanism, same receptor activation — in a daily tablet you take on an empty stomach with water.
The gradual approach
Start at 3mg. See how your body responds. Move to 7mg if it makes sense. You're not committing to the maximum dose from day one — you're building a protocol that respects your body's feedback.
Oral vs. Injectable — what the data says
| Oral Semaglutide | Injectable Semaglutide | |
|---|---|---|
| Dosing | Daily tablet (3mg, 7mg, 14mg) | Weekly injection (0.25–2.4mg) |
| Weight loss (14mg oral vs 2.4mg inject) | ~15% at 14mg (OASIS 1) | ~15% at 2.4mg (STEP 1) |
| Cardiovascular data | PIONEER 6: non-inferior. SOUL trial results pending. | SELECT: 20% MACE reduction |
| How you take it | Empty stomach, 4oz water, wait 30min before food | Subcutaneous injection, any time |
| Flexibility | Can adjust daily — easier to find your sweet spot | Locked into weekly dose cycle |
| Side effects | Same profile — nausea most common, dose-dependent | Same profile + injection site reactions |
Key insight: The oral form at higher doses (14mg+) achieves comparable weight loss to injectable. But at lower doses (3-7mg), it offers meaningful metabolic and anti-inflammatory benefits with fewer side effects — making it ideal for the health optimization use case.
Clinical evidence for oral semaglutide
OASIS 1
Knop et al., Lancet 202315.1% weight loss with oral semaglutide 50mg over 68 weeks
- - 667 participants with obesity, no diabetes
- - Comparable to injectable 2.4mg results
- - Higher oral doses (25mg, 50mg) now in development
PIONEER Program (1-10)
Multiple, 2019-2022Comprehensive safety and efficacy across 10 Phase 3 trials
- - 9,000+ participants across all PIONEER trials
- - Consistent HbA1c and weight reductions
- - PIONEER 6: cardiovascular safety confirmed (HR 0.79)
- - Well-tolerated across diverse populations
Anti-Inflammatory at Lower Doses
Multiple sourcesCRP reduction observed even at sub-maximal doses
- - PIONEER 1: CRP reduced at 7mg and 14mg doses
- - Inflammatory marker improvement independent of weight change
- - Suggests direct anti-inflammatory mechanism at any therapeutic dose
- - Supports use for metabolic health even without significant weight loss goals
Our approach to dosing
Most platforms default to escalating you to the highest dose as fast as possible. More weight loss = better testimonial = more marketing material.
We think differently. Your dose should match your goal:
Establish tolerance. Begin receptor activation. Minimal side effects.
Anti-inflammatory benefits. Moderate appetite regulation. Sustainable long-term.
Significant weight loss. Full metabolic effect. For when weight is the primary goal.
Your physician will recommend a starting dose and titration schedule based on your goals, health history, and how your body responds. You stay in control of the conversation.
How to take it
Take on an empty stomach with no more than 4oz of plain water.
30 minutes minimum before eating, drinking, or other medications.
Same time each day. Consistency matters for absorption.
No refrigeration. No injection supplies. Just a tablet.
Ready to explore this?
5-minute assessment. A physician reviews your profile and goals. If approved, tablets ship to your door monthly.
Start your assessmentNot sure yet? Read the full evidence base first.